Augmatrix is designed for use with bone marrow aspirate and has been cleared for use in multiple environments, such as fracture repair and general bone void filling procedures.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Implants:
Hospital for Special Surgery Research Analyzes Hip Implant Failures
Wright Medical Group Receives FDA Clearance for Patient-Specific Total Ankle Replacement
43 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in January
BioMimetic Therapeutics Introduces New Bone Graft Substitute
BioMimetic Therapeutics introduced the Augmatrix Biocomposite Bone Graft, a new bone graft substitute product line composed of carbonate-apatite and Type 1 collagen, according to a company news release.
From manual to manageable: How AI and partnerships are transforming urology RCM
Recommended Whitepaper